Publications en collaboration avec des chercheurs de Hospital Universitario Puerta de Hierro (21)

2024

  1. Increased incidence and mortality from Listeria monocytogenes infection in Spain

    International Journal of Infectious Diseases, Vol. 145

  2. Low-coverage whole genome sequencing for a highly selective cohort of severe COVID-19 patients

    GigaByte, Vol. 2024

  3. Obelisks – Newly discovered virus-like particles

    AIDS Reviews

  4. Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals

    AIDS reviews, Vol. 25, Núm. 4, pp. 162-172

  5. Prospects for Controlling Hepatitis B Globally

    Pathogens, Vol. 13, Núm. 4

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy

    Drug Design, Development and Therapy, Vol. 17, pp. 155-166

  3. Genetic signature detected in T cell receptors from patients with severe COVID-19

    iScience, Vol. 26, Núm. 10

  4. Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain

    Alimentary Pharmacology and Therapeutics, Vol. 57, Núm. 5, pp. 540-548

  5. Safety considerations in the management of hepatitis C and HIV co-infection

    Expert Opinion on Drug Safety, Vol. 22, Núm. 5, pp. 363-372

  6. Susceptibility to hepatitis B virus infection in adults living in Spain

    Liver International, Vol. 43, Núm. 5, pp. 1015-1020

  7. Treatment of hepatitis delta and HIV infection

    Liver International, Vol. 43, Núm. S1, pp. 108-115

  8. Viral hepatitis in persons living with HIV in the post-COVID era

    AIDS reviews, Vol. 25, Núm. 1, pp. 1-13

2022

  1. Is SARS-CoV-2 the only cause of long-COVID?

    AIDS Reviews, Vol. 24, Núm. 4, pp. 183-196

  2. Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies: on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network

    International Journal of Infectious Diseases, Vol. 122, pp. 970-975

  3. Ultra-long-acting antivirals as chemical vaccines to prevent viral diseases

    Future Microbiology, Vol. 17, Núm. 11, pp. 887-897

2021

  1. Envisioning a hepatitis delta cure with new antivirals

    Future Microbiology, Vol. 16, Núm. 13, pp. 927-930

  2. Main differences between the first and second waves of COVID-19 in Madrid, Spain

    International Journal of Infectious Diseases, Vol. 105, pp. 374-376

  3. Third wave of COVID-19 in Madrid, Spain

    International Journal of Infectious Diseases, Vol. 107, pp. 212-214

2019

  1. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2